Ftse Mib
33.447,07
0,68%
DAX
18.174,69
0,59%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.731,40
1,18%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ bioAffinity Technologies Inc (BIAF) bioAffinity Technologies Inc (BIAF) Notizie

BIAF

bioAffinity Technologies (BIAF)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIAF
DataOraFonteTitoloSimboloCompagnia
12/06/202414:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
15/05/202415:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
02/05/202414:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
24/04/202414:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
09/04/202414:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
01/04/202415:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202419:15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202418:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
08/03/202418:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
06/03/202416:45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
06/03/202415:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
05/03/202414:00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
06/02/202414:00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
02/02/202422:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
30/01/202414:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
23/01/202414:00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
08/01/202414:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
08/12/202322:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
05/12/202314:00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFbioAffinity Technologies Inc
30/11/202314:00Business WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFbioAffinity Technologies Inc
28/11/202314:00Business WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFbioAffinity Technologies Inc
28/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIAFbioAffinity Technologies Inc
16/11/202323:23Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BIAFbioAffinity Technologies Inc
15/11/202314:00Business WirebioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202322:01Business WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFbioAffinity Technologies Inc
14/11/202321:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFbioAffinity Technologies Inc
06/11/202314:00Business WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFbioAffinity Technologies Inc
03/11/202321:49Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BIAFbioAffinity Technologies Inc
03/11/202321:45Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BIAFbioAffinity Technologies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BIAF

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
SGF
Sogefi
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
SRG
Snam
BIT
1NVDA
NVIDIA
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network